Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
UY34992A
SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
WO2014023814A1
New antibacterial compounds
WO2014023813A1
Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
AU2013276520A1
1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
CA2873916A1
4-substituted 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antivira agents
CN104540817A
1,3-dihydro-2H-benzimidazol- 2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
KR20150032283A
1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
WO2013164380A1
Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
TW201341371A
4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B
KR20150000871A
4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B
CA2858659A1
Hetero-bicyclic derivatives as hcv inhibitors
CN104159914A
HIV membrane fusion inhibitors
KR20140090185A
Purine derivatives for the treatment of viral infections
CN103748081A
Quinazoline derivatives for the treatment of viral infections and further diseases
EP1896450A1
2-substituted benzimidazoles
RS53062B
Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
BRPI0607827A2
protease inhibitor precursor compound, process for producing said compound and its use
BRPI0607811A2
2- (4-cyanophenylamine) pyrimidine oxide derivatives of hiv inhibitors, pharmaceutical composition understanding the process for preparing such composition and use
